Chemoinformaics analysis of 5-Ethyl-3,8-dimethyl-1,6-dihydroazulene
| Molecular Weight | 302.282 | nRot | 2 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 18 |
| Exact Molecular Weight | 302.079 | nRing | 3 |
| Solubility: LogS | -3.828 | nHRing | 1 |
| Solubility: LogP | 2.791 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 40.8671 |
| nHD | 3 | BPOL | 18.3849 |
| QED | 0.789 |
| Synth | 3.008 |
| Natural Product Likeliness | 1.673 |
| NR-PPAR-gamma | 0.914 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.003 |
| HIA | 0.01 |
| CACO-2 | -4.868 |
| MDCK | 0.00000849 |
| BBB | 0.035 |
| PPB | 0.938225 |
| VDSS | 0.835 |
| FU | 0.0589407 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.677 |
| CYP2c19-inh | 0.692 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.711 |
| CYP2c9-sub | 0.951 |
| CYP2d6-inh | 0.721 |
| CYP2d6-sub | 0.776 |
| CYP3a4-inh | 0.89 |
| CYP3a4-sub | 0.152 |
| CL | 14.456 |
| T12 | 0.754 |
| hERG | 0.092 |
| Ames | 0.101 |
| ROA | 0.668 |
| SkinSen | 0.937 |
| Carcinogencity | 0.129 |
| EI | 0.914 |
| Respiratory | 0.762 |
| NR-Aromatase | 0.032 |
| Antiviral | Yes |
| Prediction | 0.887625 |